Cargando…

The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma

BACKGROUND: Pulmonary sarcomatoid carcinoma is characterized by poor survival rates compared with other non-small cell lung cancer. Prognostic nutritional index has significant prognostic value in many malignant tumors. We conducted this retrospective study to investigate the role of prognostic nutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Cao, Yu, Liu, Junfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722437/ https://www.ncbi.nlm.nih.gov/pubmed/33372627 http://dx.doi.org/10.1186/s13569-020-00148-2

Ejemplares similares

Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma
por: Zhao, Chenguang, et al.
Publicado: (2022)

Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma
por: Wang, Zhixian, et al.
Publicado: (2018)

Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
por: Sun, Jiachun, et al.
Publicado: (2022)

Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases
por: Huang, Si-Yuan, et al.
Publicado: (2013)

Prognostic factors in patients undergoing pulmonary resection for sarcomatoid carcinomas of the lung
por: Özkan, Berker, et al.
Publicado: (2021)

Pulmonary sarcomatoid carcinoma: University of Cincinnati experience
por: Karim, Nagla Abdel, et al.
Publicado: (2017)

Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis
por: Gang, Jin, et al.
Publicado: (2021)

Pulmonary sarcomatoid carcinoma: progress, treatment and expectations
por: Li, Xin, et al.
Publicado: (2020)

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma
por: Takeda, Kazuya, et al.
Publicado: (2016)

MET alterations in advanced pulmonary sarcomatoid carcinoma
por: Gong, Chen, et al.
Publicado: (2022)

Pulmonary sarcomatoid carcinoma: a case report
por: Shen, Xiao-yong, et al.
Publicado: (2013)

Clinicopathological features and prognostic analysis of metastatic pulmonary sarcomatoid carcinoma: a SEER analysis
por: Xiao, Congjia, et al.
Publicado: (2021)

Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
por: Agrawal, Anand
Publicado: (2020)

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
por: Sim, Jae Kyeom, et al.
Publicado: (2018)

Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma
por: Baldovini, Chiara, et al.
Publicado: (2019)

Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
por: Wang, Le, et al.
Publicado: (2021)

Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment
por: Gong, Ting, et al.
Publicado: (2022)

Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma
por: Akaba, Tomohiro, et al.
Publicado: (2023)

Clinical outcomes of radical radiotherapy for pulmonary sarcomatoid carcinoma
por: Lee, Choong-won, et al.
Publicado: (2023)

Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study
por: Wang, Feng, et al.
Publicado: (2023)

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma
por: Yu, Yingying, et al.
Publicado: (2022)

The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

Sarcomatoid Carcinoma of the Prostate
por: Açıkgöz, Onur, et al.
Publicado: (2013)

Sarcomatoid carcinoma of the cervix
por: Nageeti, Tahani H., et al.
Publicado: (2012)

Sarcomatoid carcinoma of the lung
por: Karmakar, Saurabh, et al.
Publicado: (2021)

Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
por: Li, Xin, et al.
Publicado: (2017)

Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma
por: Zeng, Qingpeng, et al.
Publicado: (2021)

Pulmonary Sarcomatoid Carcinoma Associated with Arterial Thromboembolism in a Cat
por: Guarino, Aria L., et al.
Publicado: (2021)

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022)

Recurrence of pulmonary sarcomatoid carcinoma presenting as haemothorax: a case report
por: Su, Chen, et al.
Publicado: (2023)

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
por: Zeng, Zhimin, et al.
Publicado: (2023)

Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma
por: Liang, Xiaohong, et al.
Publicado: (2020)

Prognostic factors for sarcomatoid carcinomas of lung: A single-centre experience
por: Sayan, Muhammet, et al.
Publicado: (2020)

Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report
por: Qin, Zhonghua, et al.
Publicado: (2019)

Sarcomatoid carcinoma of the gall bladder
por: Kataria, K, et al.
Publicado: (2012)

Primary Adrenal Sarcomatoid Carcinoma
por: Shaikh, Aftab S., et al.
Publicado: (2014)

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database
por: Chen, Mingjing, et al.
Publicado: (2021)

New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles
por: Nakagomi, Takahiro, et al.
Publicado: (2018)

Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
por: Chen, Fangmin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l6903upa2gan4qaeud89rluarq